On issues of performance, for example, ensuring excipient compatibility is an important aspect of any drug formulation process, and we can help. Also factors such as particle size, polymorphism, pH stability and pH solubility can influence active ingredient bioavailability and hence drug activity, and our laboratories can help you optimise these parameters.
We can also help underpin the quality, safety and efficacy of your new drug formulation by providing services that support your clinical trials and regulatory submissions. This includes comprehensive, phase-appropriate analytical method development for both the active pharmaceutical ingredient (API) and the drug undergoing development.
Drawing on the expertise of RSSL in areas such as method development and validation, physical sciences, stability testing, microscopy, metals analysis and flavour analysis, our dedicated and knowledgeable teams have the capability, techniques and equipment to support a wide range of formulation types throughout the drug development lifecycle from early phase to finished product release and import testing.